An example of a comprehensive approach to increase the access to evidence-based tobacco cessation support for smokers with rheumatic diseases
Introduction For a comprehensive approach to adult smoking cessation, contributions by all physicians are more relevant than individual efforts. This study is an example of a collaboration that aims to increase access to smoking cessation assistance for smokers with rheumatic diseases. Methods For...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Publishing
2023-11-01
|
| Series: | Population Medicine |
| Subjects: | |
| Online Access: | https://www.populationmedicine.eu/An-example-of-a-comprehensive-approach-to-increase-the-access-to-evidence-based-tobacco,175000,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction
For a comprehensive approach to adult
smoking cessation, contributions by all physicians are more
relevant than individual efforts. This study is an example
of a collaboration that aims to increase access to smoking
cessation assistance for smokers with rheumatic diseases.
Methods
For this prospective cohort study, data were
collected from adult current smokers diagnosed with
inflammatory rheumatic disease. Brief cessation
interventions were implemented by their primary
rheumatology physician and they were informed about
the smoking cessation service of the hospital. Upon their
acceptance, their appointment to SCC was immediately
arranged within the schedule of the clinic. After the
intervention, their quit status was evaluated and confirmed
by exhaled air carbon monoxide measurement at third
month. Multivariate logistic regression models were used to
evaluate the associated factors with successful quit status.
Results
The mean age of the total 184 patients was 45.5
(SD=12.4) years, and 43.4% were female. The majority
consisted of patients with rheumatoid arthritis (46.1%)
and ankylosing spondylitis (38.0%). Of the patients, 117
(63.5%) were willing to quit. At third month, quit rate of
the total group was 13.5%; 21.3% of the willing group, and
0% among the non-willing group. Among the willing group,
39% of those admitted to the cessation clinic and 14% of
the non-admitters had successfully quit smoking (p<0.05).
Application to the smoking cessation clinic had the highest
association with successful quit attempts (OR=8.126; 95% CI:
2.488–26.536). The Fagerström test score (OR=0.672; 95%
CI: 0.506–0.892) and the income level (OR=0.269; 95% CI:
0.089–0.810) were negatively associated determinants.
Conclusions
The highest cessation success was achieved in
patients who applied to the smoking cessation outpatient
clinic. Rheumatologists should build an effective bridge with
smoking cessation centers for their smoker patients. |
|---|---|
| ISSN: | 2654-1459 |